Astec LifeSciences Limited

Astec LifeSciences Limited

Astec LifeSciences Limited has informed the Exchange regarding its Annual General Meeting and Annual Report 2025-26.

Astec LifeSciences Limited

Astec LifeSciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on July 31, 2026 and Annual Report 2025-26.

Astec LifeSciences Limited

Astec LifeSciences Limited has informed the Exchange regarding Change in Director(s) of the company, with the appointment of four new directors, including two non-executive and two executive directors, and the approval of related party transactions with Godrej Agrovet Limited and Godrej Industries Limited.

Astec LifeSciences Limited

Astec LifeSciences Limited has informed the Exchange regarding the outcome of the postal ballot and the disclosure of the scrutinizer's report and voting results. The company has passed the resolutions for the appointment of new directors, including Mr. Vishal Sharma, Mr. Burjis N. Godrej, Mr. Arijit Mukherjee, and Mr. Mathew Eipe, and the approval of related party transactions with Godrej Agrovet Limited and Godrej Industries Limited.

Astec LifeSciences Limited

Astec LifeSciences Limited has informed the Exchange regarding the outcome of the postal ballot and disclosure of the Scrutinizer's Report & Voting Results. The company has passed the resolutions for the appointment of new directors, including Mr. Vishal Sharma, Mr. Burjis N. Godrej, Mr. Arijit Mukherjee, and Mr. Mathew Eipe, and related party transactions with Godrej Agrovet Limited and Godrej Industries Limited.

Astec LifeSciences Limited

Astec LifeSciences Limited has informed the Exchange about postal ballot. The company has passed several resolutions, including the appointment of new directors and approval of related party transactions.

Astec LifeSciences Limited

Astec LifeSciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window will be closed from 1st July, 2026 till 48 hours after the declaration of the Unaudited Financial Results for the Quarter ending on 30th June, 2026.

Astec LifeSciences Limited

Astec LifeSciences Limited has informed the Exchange about the publication of a public notice regarding the 32nd Annual General Meeting (AGM) to be held on July 31, 2026, through Video Conferencing (VC) or Other Audio-Visual Means (OAVM).

Astec LifeSciences Limited

Godrej Agrovet Limited, as part of the promoter group of Astec LifeSciences Limited, submitted its annual declaration under SEBI Takeover Regulations. The declaration confirms that the promoter group, along with persons acting in concert, did not encumber (pledge) any of their shareholding in Astec LifeSciences Limited during the financial year 2025-26. This filing is a routine compliance requirement, confirming stable promoter holdings.

Astec LifeSciences Limited

Astec LifeSciences Limited announced a disclosure filed by Ashok V. Hiremath under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This specific regulation typically relates to the release of previously encumbered or pledged shares by promoters or persons in control of a company. For investors, this suggests that a portion of promoter shares, which may have been used as collateral, are no longer pledged. This could be viewed as a positive sign, potentially indicating reduced financial leverage or risk for the promoter and the company.